MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002)

NCT05700734 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business Reasons

Conditions

HIV-1
Human Immunodeficiency Virus 1
Immunodeficiency Virus Type 1, Human
Human Immunodeficiency Virus Type 1

Interventions

DRUG: MK-8510

Sponsor

Merck Sharp & Dohme LLC